Request for Applications: Consortium of Multiple Sclerosis Centers (CMSC) / NARCOMS 2016 Fellowships
The Consortium of Multiple Sclerosis Centers (CMSC) and NARCOMS are pleased to announce a funding opportunity for a one-year fellowship working with both organizations.
Purpose of the Annual Awards:
This fellowship is offered to neurologists and other physicians to provide the opportunity to learn the latest techniques in patient management and care and to help foster their careers as MS physicians. It is available for 3, 6 or 12 months and must be performed under the direction of a senior clinical mentor at a European MS clinic and/or MS research center. Fellows may come from any location but priority will be given to candidates from developing countries.
This fellowship is offered to young postdoctoral neuroscientists to facilitate their conduct of and training in basic, clinical or applied research related to MS in European laboratories or clinics. The goal is to maximize exchange of information and help grow the pool of well-trained scientists focused on MS.
ECTRIMS and the European MAGNIMS (Magnetic Resonance in MS) network jointly support a postdoctoral fellowship to foster the development of young researchers in magnetic resonance studies in MS. The goal of this programme is to achieve transfer and broadening of knowledge regarding the application of magnetic resonance to MS research and to promote the researcher’s integration into the international scientific community.
ECTRIMS will support two fellowships annually, each with duration of 1 year, with an annual stipend of up to €50,000.
The Grant for Multiple Sclerosis Innovation (GMSI) 2016, a grant sponsored by Merck, offers up to €1,000,000 to academic researchers working to improve the understanding of Multiple Sclerosis (MS) for the ultimate benefit of patients. The grant is open to research applications until Monday 8th February 2016. Additional information about the grant can be found at http://www.grantformultiplesclerosisinnovation.org.
The Guthy-Jackson Charitable Foundation is dedicated to funding basic science research to find answers that will lead to the prevention, clinical treatment programs, and a potential cure for Neuromyelitis Optica (NMO) Spectrum Disease. It funds only NMO research, not MS research.
MS Research Australia offers a range of grants, fellowships, and scholarships to support research into finding better treatments and a cure for MS.
To view past program announcements, please visit the MSRP Program Announcement Archives. More program information can be found here.
The Multiple Sclerosis Society funds research into a wide range of topics including stem cells, immunology, symptom relief, and MS services.
The Multiple Sclerosis Scientific Research Foundation is the largest fund in the world dedicated strictly to MS research. The foundation funds research projects beyond the scope of the MS Society’s regular research program. It is a unique Canadian resource. Because of the foundation, highly innovative, large, collaborative research studies are under way.
The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality. This annual prize, made possible by the generosity of the Charles and Margery Barancik SO Foundation, is $100,000 to be used at the discretion of the recipient.
Finding a way to stop MS, restore function and end MS forever will require a cadre of well-trained scientists engaged in MS-related research. The Society’s Career Transition Fellowship addresses this need by fostering the development and productivity of young scientists who have potential to make significant contributions to MS research and help ensure the future and stability of MS research. The Career Transition Fellowship targets current postdoctoral trainees who demonstrate both commitment and exceptional potential to conduct MS-related research.
Physician scientists (scientists with MDs, versus PhDs) are vital to research involving persons with MS. The National MS Society and American Brain Foundation have joined to support training for young clinicians committed to careers in academic medicine with an emphasis on MS clinical research. The NMSS-ABF MS Clinician-Scientist Development Award supports 3 years of research training in an environment where talented young clinicians address problems in MS with the most current scientific tools.
Ending MS requires a cadre of well-trained scientists engaged in MS-related research. Named for a member of the Board of Directors of the National MS Society who displayed a special interest in MS research, the Daniel Haughton Senior Faculty award addresses this need by providing support to established investigators for specialized training in a field which they are not currently expert, to enhance their capacity to conduct research related to MS. Awards of this type, which are available annually, can be used for sabbatical support for qualified individuals.
Harry Weaver, Ph.D., known worldwide for his contribution to neurosciences and multiple sclerosis research, was the Society's Director of Research from 1966-1977. Throughout his tenure with the Society and throughout his career, Dr. Weaver continued to encourage young investigators to enter and pursue MS research, and to broaden our understanding of basic and clinical aspects of MS. In recognition of Dr. Weaver's contribution to the neurosciences and MS research, and to his dedication to young researchers, the Society named this prestigious Award in his honor.
The National Multiple Sclerosis Society announces the following funding opportunities:
Health Care Delivery and Policy Research Contracts:
The John Dystel Prize for Multiple Sclerosis Research is awarded jointly by the National Multiple Sclerosis Society and the American Academy of Neurology (AAN). The Prize, currently in the amount of $15,000, recognizes outstanding contributions to research in the understanding, treatment or prevention of multiple sclerosis. The prize is intended to recognize significant and exciting work which has influenced the way we think about multiple sclerosis, but it is not to be a lifetime achievement award.
